Department of Biochemistry

March 5, 2015

Vanderbilt team first to blend high-end imaging techniques

Vanderbilt University researchers have achieved the first “image fusion” of mass spectrometry and microscopy — a technical tour de force that could, among other things, dramatically improve the diagnosis and treatment of cancer.

By Bill Snyder
February 26, 2015

Center for Structural Biology symposium to feature stellar lineup

The Vanderbilt University Department of Biochemistry will host a two-day symposium March 6-7 to honor the 60th birthday of Walter Chazin, Ph.D., director of the Center for Structural Biology.

By VUMC News and Communications
February 25, 2015

Antibiotics with anticancer potential

A series of experimental antibiotics may be a good starting point for developing new anticancer drugs.

By Leigh MacMillan
January 29, 2015

Grant bolsters pancreatic cancer drug discovery efforts

The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer.

By VUMC News and Communications
January 2, 2015

Genome-editing pioneer next up in Discovery Lecture series

Jennifer Doudna, Ph.D., recipient of a 2015 Breakthrough Prize in Life Sciences, will deliver the next Flexner Discovery Lecture on Thursday, Jan. 8.

By Leigh MacMillan
September 4, 2014

VU study creates new road map for cellular activity

Human cells are constructed in large part from proteins whose activity can be altered by the incorporation of oxygen in what are known as redox modifications.

By VUMC News and Communications
August 28, 2014

Ascano seeks to shed light on cellular stress response

Ebola. Chikungunya. Influenza. What’s to be done about these headline-grabbing, debilitating, often lethal viruses?
By Bill Snyder
May 23, 2014

Repair protein’s DNA recognition motif

Insights into the workings of DNA damage response proteins such as SMARCAL1 could suggest new ways to improve genome integrity and prevent cancer.
By Leigh MacMillan
May 9, 2014

Bypassing DNA damage

Studies of a human polymerase that replicates DNA have provided a complete kinetic and structural framework for understanding how the enzyme accurately bypasses DNA damage.
By VUMC News and Communications
March 13, 2014

A new way to target cancer-driver Ras

Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way.
By Leigh MacMillan
March 3, 2014

Dismantling staph’s drug resistance

Targeting the enzyme FosB could make antibiotic-resistant staph bacteria sensitive to the antibiotic fosfomycin.
By Leigh MacMillan
November 7, 2013

VU study sheds new light on DNA replication

David Cortez, Ph.D., and his Vanderbilt colleagues report new findings that shed light on fundamental processes involved in DNA replication and have implications for cancer therapies that target these processes.
By Leigh MacMillan
September 16, 2013

Mapping brain membrane proteins

New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.
By Leigh MacMillan
1 … 8 9 10 11